Argus Investors' Counsel, Inc. Stryker Corp Transaction History

Argus Investors' Counsel, Inc.

$148 Million
Q3 2024

A detailed history of Argus Investors' Counsel, Inc. transactions in Stryker Corp stock. As of the latest transaction made, Argus Investors' Counsel, Inc. holds 5,741 shares of SYK stock, worth $2.24 Million. This represents 1.4% of its overall portfolio holdings.

Number of Shares

5,741

Previous 7,171 19.94%

Holding current value

$2.24 Million

Previous $2.44 Million 15.01%

% of portfolio

1.4%

Previous 1.52%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	SELL	$315.94 - $371.96 $451,794 - $531,902	-1,430 Reduced 19.94%	5,741 $2.07 Million
Q2 2024 Jul 22, 2024	BUY	$324.3 - $354.67 $1.52 Million - $1.66 Million	4,685 Added 188.46%	7,171 $2.44 Million
Q2 2024 Jul 19, 2024	SELL	$324.3 - $354.67 $1.48 Million - $1.62 Million	-4,558 Reduced 64.71%	2,486 $845,000
Q1 2024 Apr 24, 2024	SELL	$293.94 - $358.71 $304,227 - $371,264	-1,035 Reduced 12.81%	7,044 $2.52 Million
Q4 2023 Jan 19, 2024	BUY	$253.85 - $299.46 $4,061 - $4,791	16 Added 0.2%	8,079 $2.42 Million
Q3 2023 Oct 17, 2023	SELL	$266.54 - $302.43 $59,171 - $67,139	-222 Reduced 2.68%	8,063 $2.2 Million
Q2 2023 Jul 20, 2023	BUY	$271.49 - $305.09 $29,863 - $33,559	110 Added 1.35%	8,285 $2.53 Million
Q1 2023 Apr 20, 2023	SELL	$246.13 - $285.47 $3,445 - $3,996	-14 Reduced 0.17%	8,175 $2.33 Million
Q4 2022 Jan 18, 2023	BUY	$205.51 - $253.93 $2,260 - $2,793	11 Added 0.13%	8,189 $0
Q3 2022 Oct 18, 2022	SELL	$189.27 - $231.83 $291,854 - $357,481	-1,542 Reduced 15.86%	8,178 $1.66 Million
Q2 2022 Jul 22, 2022	BUY	$194.09 - $276.37 $52,792 - $75,172	272 Added 2.88%	9,720 $1.93 Million
Q1 2022 May 04, 2022	BUY	$245.33 - $277.77 $42,196 - $47,776	172 Added 1.85%	9,448 $2.53 Million
Q4 2021 Jan 25, 2022	SELL	$236.63 - $276.44 $29,815 - $34,831	-126 Reduced 1.34%	9,276 $2.48 Million
Q3 2021 Oct 20, 2021	SELL	$248.9 - $280.09 $1.96 Million - $2.2 Million	-7,866 Reduced 45.55%	9,402 $2.48 Million
Q2 2021 Jul 30, 2021	SELL	$242.95 - $267.0 $396,008 - $435,210	-1,630 Reduced 8.63%	17,268 $4.49 Million
Q1 2021 Apr 19, 2021	BUY	$221.01 - $248.82 $33,372 - $37,571	151 Added 0.81%	18,898 $4.6 Million
Q4 2020 Jan 27, 2021	SELL	$202.01 - $245.04 $754,709 - $915,469	-3,736 Reduced 16.62%	18,747 $4.59 Million
Q3 2020 Oct 30, 2020	SELL	$177.77 - $215.81 $150,748 - $183,006	-848 Reduced 3.63%	22,483 $4.69 Million
Q2 2020 Jul 27, 2020	BUY	$144.67 - $207.03 $92,154 - $131,878	637 Added 2.81%	23,331 $4.2 Million
Q1 2020 Apr 24, 2020	SELL	$126.5 - $225.1 $181,780 - $323,468	-1,437 Reduced 5.95%	22,694 $3.78 Million
Q4 2019 Jan 17, 2020	BUY	$197.98 - $220.53 $70,480 - $78,508	356 Added 1.5%	24,131 $5.07 Million
Q3 2019 Oct 17, 2019	SELL	$205.4 - $221.82 $159,185 - $171,910	-775 Reduced 3.16%	23,775 $5.14 Million
Q2 2019 Jul 10, 2019	BUY	$180.24 - $205.58 $4.36 Million - $4.97 Million	24,166 Added 96.92%	49,100 $10.1 Million
Q2 2019 Jul 10, 2019	SELL	$180.24 - $205.58 $4.42 Million - $5.05 Million	-24,550 Reduced 50.0%	24,550 $5.05 Million
Q1 2019 Apr 16, 2019	BUY	$152.46 - $198.0 $74,552 - $96,822	489 Added 2.0%	24,934 $4.93 Million
Q4 2018 Feb 06, 2019	SELL	$145.0 - $178.65 $289,855 - $357,121	-1,999 Reduced 7.56%	24,445 $3.83 Million
Q3 2018 Oct 16, 2018	SELL	$163.25 - $177.68 $114,275 - $124,376	-700 Reduced 2.58%	26,444 $0
Q2 2018 Jul 19, 2018	SELL	$155.17 - $179.78 $202,807 - $234,972	-1,307 Reduced 4.59%	27,144 $4.58 Million
Q1 2018 May 15, 2018	SELL	$148.01 - $168.91 $13,764 - $15,708	-93 Reduced 0.33%	28,451 $4.04 Million
Q4 2017 Jan 23, 2018	BUY	$143.51 - $159.74 $13,346 - $14,855	93 Added 0.33%	28,544 $4.42 Million
Q3 2017 Oct 06, 2017	BUY	$138.36 - $147.87 $3.94 Million - $4.21 Million	28,451	28,451 $4.04 Million

Others Institutions Holding SYK

# of Institutions

2,230

Shares Held

285M

Call Options Held

1.35M

Put Options Held

1.6M

View Full List

About STRYKER CORP

Ticker SYK
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 378,320,992
Market Cap $147B
Description
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...

More about SYK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Argus Investors' Counsel, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Argus Investors' Counsel, Inc. with notifications on news.

Account

Argus Investors' Counsel, Inc. Stryker Corp Transaction History